A biotechnology start-up called Koniku Inc is trying to develop robots that could sniff out COVID-19 infections faster than conventional testing.
The technology fuses neurons with a silicon chip to create a “smell cyborg” capable of detecting scents ranging from explosives to pathogens.
Koniku’s first clinical trial began three weeks ago and would examine samples from patients tested for COVID-19 to compare how well the smell-bot detects the virus compared with traditional methods.
Photo: AFP
Small internal trials have already demonstrated that it can accurately detect the presence of influenza A.
“Our goal is to have a device that merges synthetic biology with silicon and maps all of the smells of human life on a global scale,” said Oshiorenoya Agabi, the San Rafael, California-based company’s chief executive officer and cofounder. “We should have a device in every home in America to screen for disease.”
Pathogens produce unique volatile organic compounds, scent-fingerprints of a sort, released by ailing cells. These signature smells are the same biological clues that allow dogs to sniff out dozens of diseases. Finland last month tested the ability of dogs to detect COVID-19 in a trial at Helsinki’s airport.
Some researchers have suggested that using dogs could be cheaper, faster and even potentially more effective in screening for the disease than methods including temperature checks, nasal swabs and saliva.
In July, German researchers showed that trained dogs were able to distinguish between saliva sampled from people infected with the virus and those who were not more than 90 percent of the time.
Koniku’s device, the Konikore, is slightly smaller than a frisbee and resembles a flying saucer. When the proteins in its chip bind to a scent it has been programmed to detect, cells amplify and process those signals with help from machine learning, and the device lights up.
In a field test in Alabama, it was able to detect explosives better than trained dogs. The test was conducted by law enforcement officials and aerospace giant Airbus SE, a Koniku investor and partner that has been working to roll out the technology in airports.
Koniku plans to conduct field trials with Airbus at Changi Airport in Singapore and then San Francisco International Airport later this year.
“If a dog can smell it, we can,” said Agabi, who described the Konikore as a “smell camera.”
He imagines the technology could be useful far beyond bombs and diseases.
For example, it could digitize the taste of food, allowing for the synthetic recreation of things like bacon, he said.
Koniku’s merger of biology and computing technology — often termed “wetware” — is a growing field. The company’s investors include Softbank Group Corp, Platform Capital Group, Halfcourt Ventures LLC, Changi Airport and Airbus’ venture capital arm.
Koniku has hired Treximo LLC, a biotech consulting and project management company, to conduct its trials for SARS-CoV-2. Trials for new devices are typically far faster and less intensive than those for new drugs.
Treximo said it expects it would be done with the necessary steps to apply for an emergency-use authorization with the US Food and Drug Administration in the first quarter of next year.
“We know this device can smell explosives, but can we have it pick up organic compounds in human breath to say yes or no does this person have SARS-CoV-2?” Treximo chief executive officer Michael Stomberg said. “It’s a game-changing device if it proves to be valid.”
The devices are to go on pre-sale for hardware developers this week.
After COVID-19, Agabi imagines the company pursuing other diseases insurance companies might be inclined to cover the cost of a test for, such as lung cancer.
If successful, it could be used not just in homes, but for mass detection of diseases and pathogens in public spaces.
“Telehealth is growing,” Agabi said. “Our goal is not another Zoom application, but to actually bring technology closer to people to be able to screen disease in real time.”
CHIP RACE: Three years of overbroad export controls drove foreign competitors to pursue their own AI chips, and ‘cost US taxpayers billions of dollars,’ Nvidia said China has figured out the US strategy for allowing it to buy Nvidia Corp’s H200s and is rejecting the artificial intelligence (AI) chip in favor of domestically developed semiconductors, White House AI adviser David Sacks said, citing news reports. US President Donald Trump on Monday said that he would allow shipments of Nvidia’s H200 chips to China, part of an administration effort backed by Sacks to challenge Chinese tech champions such as Huawei Technologies Co (華為) by bringing US competition to their home market. On Friday, Sacks signaled that he was uncertain about whether that approach would work. “They’re rejecting our chips,” Sacks
NATIONAL SECURITY: Intel’s testing of ACM tools despite US government control ‘highlights egregious gaps in US technology protection policies,’ a former official said Chipmaker Intel Corp has tested chipmaking tools this year from a toolmaker with deep roots in China and two overseas units that were targeted by US sanctions, according to two sources with direct knowledge of the matter. Intel, which fended off calls for its CEO’s resignation from US President Donald Trump in August over his alleged ties to China, got the tools from ACM Research Inc, a Fremont, California-based producer of chipmaking equipment. Two of ACM’s units, based in Shanghai and South Korea, were among a number of firms barred last year from receiving US technology over claims they have
It is challenging to build infrastructure in much of Europe. Constrained budgets and polarized politics tend to undermine long-term projects, forcing officials to react to emergencies rather than plan for the future. Not in Austria. Today, the country is to officially open its Koralmbahn tunnel, the 5.9 billion euro (US$6.9 billion) centerpiece of a groundbreaking new railway that will eventually run from Poland’s Baltic coast to the Adriatic Sea, transforming travel within Austria and positioning the Alpine nation at the forefront of logistics in Europe. “It is Austria’s biggest socio-economic experiment in over a century,” said Eric Kirschner, an economist at Graz-based Joanneum
OPTION: Uber said it could provide higher pay for batch trips, if incentives for batching is not removed entirely, as the latter would force it to pass on the costs to consumers Uber Technologies Inc yesterday warned that proposed restrictions on batching orders and minimum wages could prompt a NT$20 delivery fee increase in Taiwan, as lower efficiency would drive up costs. Uber CEO Dara Khosrowshahi made the remarks yesterday during his visit to Taiwan. He is on a multileg trip to the region, which includes stops in South Korea and Japan. His visit coincided the release last month of the Ministry of Labor’s draft bill on the delivery sector, which aims to safeguard delivery workers’ rights and improve their welfare. The ministry set the minimum pay for local food delivery drivers at
RSS